For the ever-growing number of patients with brain tumors, the need for better treatments and management strategies is acute. By combining laboratory and clinical data, we are able to provide an avenue toward therapies tailored to individual patients.
With the goal of targeting cancer at the molecular level, world-renowned physician/scientist Dr. Santosh Kesari heads up a team of scientists experienced in neuro-oncology and neurotherapeutics research.
Dr. Yenugonda is driven by his desire to better mankind by developing safe, effective and affordable drugs for difficult diseases that can be easily accessed by everyone. Utilizes a unique, two-pronged approach, he combines drug discovery tools and nanotechnology tools to circumvent existing clinical problems. Learn more.[ Read More ] [ See All Posts ]
For the ever-growing number of patients with skull base and brain tumors, the need for better treatments and management strategies is acute. By combining laboratory and clinical data, we are able to provide therapies tailored to individual patients. Through clinical trials and research in conjunction with the Pacific Brain Tumor Center, we provide patients with customized advanced neuro-oncology and neurotherapeutic options. In addition, our integrated neurosciences and neurotherapeutics research program explores potential cancer cures through basic science, preclinical, clinical, and translational research.
Providence Saint John’s Health Center & John Wayne Cancer Institute
Our affiliated partners in research and clinical excellence.